Latest Research in Immune cells in cancer
22 research papers · 2026 median publication year
Top Research Topics in Immune cells in cancer
- Immune cells in cancer — 3 papers
- Cancer, Hypoxia, and Metabolism — 3 papers
- Single-cell and spatial transcriptomics — 2 papers
- RNA modifications and cancer — 2 papers
- Lipid metabolism and biosynthesis — 1 papers
- Ferroptosis and cancer prognosis — 1 papers
- Circular RNAs in diseases — 1 papers
- interferon and immune responses — 1 papers
- Histone Deacetylase Inhibitors Research — 1 papers
- Telomeres, Telomerase, and Senescence — 1 papers
Highest-Cited Papers
- Multi-omics profiling reveals sphingolipid metabolism reprogramming of tumor-conditioned MDSCs in cervical cancer
- Altered Lipolytic Protein Expression in Tumor-Associated Adipose Tissue Correlates with Aggressive Breast Cancer Features
- Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis
- Role of CircRNA_0005075 in gastric cancer immune evasion through regulation of lactate metabolic reprogramming and histone lactylation
- Transcriptomic profiling of tumor-educated macrophages induced by intrahepatic cholangiocarcinoma cell-conditioned medium
- WDR12 Promotes Glucose Metabolism via PFKFB4 Upregulation in Gastric Cancer
- DCTN2 inhibited cellular senescence through targeting TRIM21 mediated MST2 ubiquitination and activation in hepatocellular carcinoma
- Multi-omics integration uncovers epigenetic control of metabolic reprogramming in triple-negative breast cancer
- Integrated single-cell and bulk RNA analysis identifies glycolysis-associated epithelial cell signatures and prognostic model in non-small cell lung cancer
- METTL3–m6A–IGF2BP2 Axis‐Mediated Stabilization of MTFR1 Promotes Glycolytic Reprogramming in Colorectal Cancer
- Sotagliflozin, a Dual SGLT1/2 Inhibitor, Modulates DNMT1 and Class I/II HDAC Expression in Association With Anticancer Effects in Breast and Lung Cancer Cells
- AI-Assisted Multimodal Transcriptomic Analysis Identifies a Senescence-Related Prognostic Signature and Characterizes ADGRF5-Associated Malignant Phenotypes in Breast Cancer
- Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia
- ROCK Inhibition Accelerates Mesenchymal-to-Epithelial Transition and Improves Early Survival During Human Fibroblast Reprogramming
- Multi-omics integration reveals ATG2A-regulated Ammonia-Induced cell death as a key driver of the immunosuppressive niche in colorectal cancer liver metastases
- Integrative single-cell and spatial transcriptomic analysis reveals 4-HNE-related stromal remodeling in lung adenocarcinoma
- UGGT1 mediates N-glycosylation of LGALS3BP to induce angiogenesis in liver cancer via the NOTCH signaling pathway
- Arachidonic acid metabolism-based stratification reveals immune microenvironment heterogeneity and defines a prognostic signature in triple-negative breast cancer
- Anti-Tumor Potential of Selective L-Type Amino Acid Transporter (LAT1) Inhibitor, JPH203, in Patient-Derived Canine Bladder Cancer Organoids
- Helicobacter pylori CagA effector protein drives gastric cancer progression via m6A/DUSP6-mediated regulation of tumor glycolysis